1927: The Pivotal Year in Asbestos Disease History

What Are the Key Facts About 1927 in Asbestos Disease History?

On December 3, 1927, the British Medical Journal published 3 coordinated asbestos papers on consecutive pages [1] — by W. E. Cooke, S. McDonald, and Sir Thomas Oliver — and Edinburgh University accepted I. M. D. Grieve's MD thesis on the J.W. Roberts factory at Armley, where roughly 1,000 surrounding houses lay in the dust path of approximately 250 asbestos workers [10]. The convergence is the documented end of the "we didn't know" defense.

For modern mesothelioma cases, 1927 is the date plaintiff attorneys cite when defendants argue the asbestos industry "did not know" its product was dangerous [3]. The 1927 record — followed by the 1928 Leadbetter inquest, the 1930 Merewether and Price report [7], and the 1931 Asbestos Industry Regulations — is the foundation on which the later 1935 Lanza study suppression evidence sits.

Why Is 1927 Considered the Pivotal Year in Asbestos Disease History?

The conventional shorthand is that 1924 was the first medical case report (Cooke on Nellie Kershaw) and 1930 was the first major government investigation (Merewether and Price). The years in between are sometimes treated as a quiet interval. They were not.

1927 was the year four independent medical observers — a pathologist (Cooke), a histologist (McDonald), the most senior occupational physician in Britain (Oliver), and a treating general practitioner (Grieve) — arrived simultaneously at the same conclusion from four different vantage points [7]. Grieve's thesis quantified the workplace risk: 100% of asbestos textile workers at J.W. Roberts developed pulmonary fibrosis within roughly 5 years of dust exposure. As Peter Bartrip wrote in his 1998 Medical History article on the Home Office and the 1931 regulations [7], before the 1927 publications references to asbestos in medical literature were "brief allusions, sequestered in lengthy sets of reports." After 1927, asbestos disease was a named entity with diagnostic criteria.

The chest specialist W. Burton Wood confessed as late as 1929 that "I have failed to find any mention of asbestos in standard works on pulmonary disease." That comment captures how recently the disease had entered formal medical discourse — and how rapidly the 1927 publications changed the available knowledge. Morris Greenberg's Knowledge of the Health Hazard of Asbestos Prior to the Merewether and Price Report of 1930 [3], the canonical pre-1930 evidence review, places the BMJ cluster squarely at the center of what should have triggered regulation years earlier than it did.

From a legal perspective, the analysis is straightforward. A company manufacturing asbestos products after late 1927 could not credibly claim it had no way to learn that its product caused a disabling and progressive lung disease. The Journal of the American Medical Association editorial of January 14, 1928 — which directly cited Cooke's BMJ paper [1] and called for "more attention" to asbestosis — is one of many contemporaneous documents that confirm the 1927 publications crossed the Atlantic immediately and entered American medical consciousness [4].

What Happened at the BMA Edinburgh Meeting in July 1927?

The British Medical Association's 95th Annual Meeting convened in Edinburgh in July 1927 under the patronage of King George V. The president that year was R. G. Hogarth, C.B.E., F.R.C.S., a senior surgeon based in Edinburgh. By the 1920s, the BMA had achieved membership rates as high as 90% of the medical profession in some regions, which made its annual meetings the central forum for the dissemination of new medical knowledge in Britain.

BMA annual meetings of that era were organized into specialist Sections — Medicine, Surgery, Preventive Medicine, Pathology, and others — with parallel sessions running over several days. Papers were read aloud and followed by open-floor discussion, a format that allowed immediate professional challenge and debate. The BMJ also published a contemporary report on the Historical Medical Exhibition held in conjunction with the Edinburgh meeting, in its August 6, 1927 issue.

The BMJ index for 1927 references asbestosis-related papers in connection with the Section of Preventive Medicine, which would have been the natural home for occupational disease presentations. The three landmark papers by Cooke, McDonald, and Oliver — published on consecutive pages of the December 3, 1927 BMJ [1] — almost certainly originated as Edinburgh meeting presentations. The clustering of three independent papers on the same disease in a single BMJ issue, by authors from different specialties, was highly unusual for the period and consistent with coordinated session presentation followed by coordinated publication [6].

Who Was W. E. Cooke, and Why Did He Name the Disease?

William Edmund Cooke was a pathologist and bacteriologist at Wigan Infirmary and Leigh Infirmary in industrial Lancashire. He came to asbestos disease through autopsy work. In 1924, he had performed the post-mortem on Nellie Kershaw, a 33-year-old asbestos textile worker who had died at the Turner Brothers Asbestos plant in Rochdale after 14 years on the job — an exposure period later associated with 50% to 87% asbestosis prevalence in similar textile cohorts. Cooke published a brief case report that year in the BMJ — the first English-language medical article on asbestos lung disease.

The 1927 paper was Cooke's fuller treatment. He had now accumulated additional case material and detailed pathological observations. In his Pulmonary Asbestosis paper of December 3, 1927 [1] (Vol. 2, No. 3491, pp. 1024–1025), he formally introduced the name "pulmonary asbestosis." He described the curious bodies found in the lung tissue — small dumbbell-shaped iron-coated structures embedded in the fibrotic parenchyma — that would later be recognized as asbestos bodies, the histological signature of asbestos exposure. The peer-reviewed history of asbestos exposure documented in the Journal of Thoracic Disease [5] credits McDonald's 1927 paper as the source that called the histological features "curious."

"Pulmonary asbestosis, as a disease entity, deserves more attention than it has had. The pathological picture is sufficiently characteristic to support a specific diagnosis."

— W. E. Cooke, "Pulmonary Asbestosis," British Medical Journal, December 3, 1927

S. McDonald's companion paper, "Histology of Pulmonary Asbestosis" (BMJ 2:1025–1026), provided the histological analysis of Cooke's case material in detail, describing the curious bodies microscopically. The two papers together established both gross pathology and histology for the disease — the foundation any later researcher would build on. The full story of Cooke's 1924 autopsy through his 1927 naming is the back-story to why 1927 mattered.

What Did Sir Thomas Oliver's Authority Add in 1927?

The single most consequential signature on a 1927 asbestos paper was Sir Thomas Oliver's. Born in Ayrshire in 1853, Oliver [9] was a Scottish physician who served as Professor of Medicine at Durham University until 1927 and was President of the College of Medicine from 1926 to 1934. He had edited the landmark volume Dangerous Trades (1902) and authored Diseases of Occupation (1908). He was knighted in 1908 for his services to public health, and he is recognized as one of the founding figures of modern British occupational medicine — yet his earlier 1,000-plus pages on industrial hazards contained virtually no discussion of asbestos.

Oliver's 1927 BMJ paper, "Clinical Aspects of Pulmonary Asbestosis" (Vol. 2, No. 3491, pp. 1026–1027), addressed the disease from the bedside — what asbestosis looked like in living patients, the clinical course, the prognosis. The choice of presenter mattered. A pathology case report by a provincial doctor was dismissed by industry critics as an isolated curiosity. A clinical paper by Sir Thomas Oliver — the man who had literally written the British book on dangerous trades — could not. The earlier editions of Dangerous Trades and Diseases of Occupation had contained essentially no discussion of asbestos hazards. Oliver's 1927 paper represented his belated but unambiguous engagement with the issue, and it transmitted his institutional authority to the topic.

Combined, the three BMJ papers signaled that asbestosis had crossed from anecdote to medical category. The historian Geoffrey Tweedale, in his definitive 2000 study Magic Mineral to Killer Dust, treats the late-1927 cluster as the documented endpoint of the period in which any company could plausibly argue the evidence was too sparse to act on. A. C. Haddow's clinical follow-up Clinical Aspects of Pulmonary Asbestosis paper in the BMJ on September 28, 1929 [2] continued the same thread of clinical documentation that Oliver's 1927 contribution opened. The Edinburgh meeting itself was reported in the BMJ's August 6, 1927 issue [6].

What Did Dr. Grieve's Edinburgh Thesis Reveal About the Workers?

Ian Martin Drever Grieve was a general practitioner in Leeds whose patients worked at J.W. Roberts Ltd. in Armley — a workforce of roughly 250 employees surrounded by 1,000 nearby houses where neighborhood children later made "snowballs" from the asbestos dust [10]. His position was unusual: not a university researcher, not a factory inspector, not a government investigator — the workers' own doctor, seeing what the dust was doing to their lungs in his consulting room.

In 1927, Grieve submitted his MD thesis to the University of Edinburgh: "Asbestosis. An investigation into the chronic pulmonary disease of asbestos workers in this country." The findings were devastating. As the business historian David Jeremy summarized in his 1995 paper on Turner & Newall's corporate response to the hazard — and as the European Environment Agency's Late Lessons from Early Warnings report later reproduced [8] — Grieve concluded:

• The pulmonary fibrosis caused by asbestos was unique — distinct from other dust diseases.
• Asbestos workers seldom survive five years in the factory without developing respiratory disease.
• The disease is progressive and does not diminish with cessation of work — it continues to advance even after the worker leaves the dust.
• The longest working life among the workers he studied was twenty-five years; the shortest was fifteen.

One paraphrase preserved in the occupational medicine literature defines Grieve's asbestosis as "a chronic pneumoconiosis affecting all asbestos workers within five years." The implication for any company employing asbestos workers was inescapable. Five years of exposure was the working lifetime over which the disease became visible. Anyone planning a workforce around an asbestos process should have understood, after 1927, that they were planning around predictable disease.

"By 1930 there had been at least 12 deaths amongst asbestos workers. The thesis by Grieve (1927) was part of the evidence base that existed prior to the Merewether and Price report."

— European Environment Agency, Late Lessons from Early Warnings: the precautionary principle 1896–2000, 2001

Grieve's access to the factory came through his clinical practice — his patients were employees of J.W. Roberts. The thesis includes a notable observation: he wrote that "the employers are so wide awake to the risks as to establish and enforce precautionary measures on a scale far beyond the requirements of the Factory and Work Shops Act." The company's own measures, in other words, signaled the company's own awareness. Yet Grieve's findings on the five-year onset of disease showed those measures were inadequate. The factory continued to operate. According to Wikipedia's Armley asbestos disaster entry [10], the dust continued to fall on the surrounding houses, where neighborhood children were later observed making "snowballs" from the asbestos dust on the playground.

How Did the Industry Respond to the 1927 Evidence?

The first documented industry response — as catalogued in the historical record of the Armley asbestos disaster [10] — was legal defense, not worker protection. In March 1928, Walter Leadbetter, a 34-year-old employee of J.W. Roberts, died from asbestos-related lung disease. At the inquest, Grieve testified as Leadbetter's physician — describing fibrosis and asbestos particles in the victim's lungs.

Turner & Newall — the parent company formed when J.W. Roberts merged with Turner Brothers Asbestos, Newalls Insulation, and the Washington Chemical Company in 1920 — dispatched counsel to cross-examine Grieve and the coroner's pathologist, Dr. Arthur Leslie Taylor of Leeds General Infirmary. T&N's counsel "questioned two of the three medical witnesses hard." T&N company secretary Walker Shepherd later wrote internally that the company had "used the small differences" between its own pathologist and Taylor in cross-examination of the coroner's pathologist. The strategy failed. The jury returned a verdict of "broncho-pneumonia and fibrosis of lungs due to asbestos dust."

The Leadbetter inquest had consequences the company could not control. HM Medical Inspector of Factories, Dr. Henry, attended. Walker Shepherd reported to T&N vice-chairman Samuel Turner that Henry was "far from being convinced" that asbestosis was real — but also that "there will be some sort of enquiry on behalf of the Home Office." That enquiry became the Merewether and Price investigation of 1928–1930 [7], which documented asbestosis across the British industry and led directly to the Asbestos Industry Regulations of 1931.

The pattern visible in Turner & Newall's 1928 response — aggressive legal defense, internal acknowledgment of risk, public denial of disease — was the template for what American asbestos manufacturers would do across the 1930s, 1940s, and beyond. The 1935 Lanza study editing by Johns-Manville and Metropolitan Life is the most heavily documented American example. The Simpson Papers — roughly 6,000 pages of internal industry correspondence from 1933 to 1943, discovered in 1977 — established that the American industry knew what the British industry already knew by the end of 1927.

How Do the 1927 Events Shape Mesothelioma Lawsuits Today?

Three concrete consequences of 1927 are still load-bearing in modern mesothelioma litigation — a litigation system in which more than 60 active Section 524(g) asbestos trusts hold approximately $30 billion in combined assets and continue to pay scheduled-value claims to qualifying victims.

First, the "knew or should have known" standard has a documented anchor date. American asbestos defendants have argued for decades that the medical and scientific community did not adequately understand asbestos hazards until the 1960s — pointing to Irving Selikoff's landmark 1964 New York Academy of Sciences conference as the supposed turning point. The 1927 publications, the 1928 JAMA editorial, the 1930 Merewether and Price report, and the 1931 British regulations contradict that framing [3]. A plaintiff attorney can show, with primary medical journal documentation, that the disease was named, diagnostic criteria were established, and a government inquiry was already underway 35 years before Selikoff. Cooke's 1927 BMJ paper, indexed on PubMed under PMID 20773543 [1], and the broader 2017 review "Toward an Asbestos Ban in the United States" [4] are documents any jury can be shown.

Second, the 1927 record shifts the burden in conduct-based claims. Compensatory damages address the patient's injury. Punitive damages and fraud-based claims address corporate conduct [11]. The earlier the documented date at which an industry should have acted, the longer the period of conduct that can be characterized as reckless or fraudulent. 1927 — followed immediately by Turner & Newall's documented legal-defense response to the Leadbetter inquest in March 1928 — extends the actionable conduct window backwards by nearly four decades from the Selikoff date defendants prefer.

Third, the 1927 evidence supports today's asbestos trust fund system. Section 524(g) of the Bankruptcy Code, codified in 1994, exists because conduct-based litigation broke companies like Johns-Manville in 1982 [12]. The conduct-based case rests on the documented gap between what the industry knew and what it told workers and the public. 1927 is one anchor of the documented knowledge side of that gap. The attorneys who file mesothelioma cases today routinely reach back to the 1927 publications in expert reports and trial exhibits, because the date is unambiguous and the publications are independently verifiable [13].

For families with a recent pleural mesothelioma diagnosis, the practical implications are unchanged from the 1980s: occupational history matters, product identification matters, and timing matters. Statutes of limitations for mesothelioma generally run from the date of diagnosis, not exposure, but the windows are short — often one to three years depending on the state. The 1927 record does not affect what families need to do now. It affects what defendants can credibly argue when families take action.

Where Can You Find the Original Sources and Further Reading?

The scholarly literature on 1927 is concentrated in a handful of authoritative sources — a corpus of roughly 1,000 pages of peer-reviewed history, archival reports, and contemporaneous BMJ records. Peter Bartrip's "Too Little, Too Late? The Home Office and the Asbestos Industry Regulations, 1931" in Medical History (1998) [7] is the standard analytical treatment of the British government response. Morris Greenberg's "Knowledge of the Health Hazard of Asbestos Prior to the Merewether and Price Report of 1930" in Social History of Medicine (1994), indexed under PMID 11639478 [3], is the canonical pre-1930 evidence review. David Jeremy's 1995 paper on Turner & Newall's corporate response, in the Business and Economic History conference proceedings, preserves the Grieve thesis findings in usable secondary form. Geoffrey Tweedale's Magic Mineral to Killer Dust: Turner & Newall and the Asbestos Hazard (Oxford University Press, 2000) remains the standard book-length corporate history. The European Environment Agency's Late Lessons from Early Warnings (2001) [8] places the 1927 evidence in the broader history of recognized-but-unaddressed industrial hazards. The original Cooke, McDonald, and Oliver papers can be located through PubMed; Cooke's is preserved under PMID 20773543 [1]. The WikiMesothelioma Asbestos History Timeline [11] compiles the surrounding dates, and the History of Mesothelioma Research [12] page tracks the medical literature forward from 1927 into the modern era.